<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lansky AJ</submitter><funding>Dutch Heart Foundation</funding><pagination>1687-1697</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6251670</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>39(19)</volume><pubmed_abstract>Surgical and catheter-based cardiovascular procedures and adjunctive pharmacology have an inherent risk of neurological complications. The current diversity of neurological endpoint definitions and ascertainment methods in clinical trials has led to uncertainties in the neurological risk attributable to cardiovascular procedures and inconsistent evaluation of therapies intended to prevent or mitigate neurological injury. Benefit-risk assessment of such procedures should be on the basis of an evaluation of well-defined neurological outcomes that are ascertained with consistent methods and capture the full spectrum of neurovascular injury and its clinical effect. The Neurologic Academic Research Consortium is an international collaboration intended to establish consensus on the definition, c</pubmed_abstract><journal>European heart journal</journal><pubmed_title>Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.</pubmed_title><pmcid>PMC6251670</pmcid><funding_grant_id>2010T075</funding_grant_id><pubmed_authors>Browndyke J</pubmed_authors><pubmed_authors>Messe SR</pubmed_authors><pubmed_authors>Brickman AM</pubmed_authors><pubmed_authors>van Es GA</pubmed_authors><pubmed_authors>Parides MK</pubmed_authors><pubmed_authors>Kodali S</pubmed_authors><pubmed_authors>Dwyer M</pubmed_authors><pubmed_authors>Popma J</pubmed_authors><pubmed_authors>Gress D</pubmed_authors><pubmed_authors>Akar J</pubmed_authors><pubmed_authors>Holmes D</pubmed_authors><pubmed_authors>Ng VG</pubmed_authors><pubmed_authors>Scala Moy C</pubmed_authors><pubmed_authors>Bilello M</pubmed_authors><pubmed_authors>Mack M</pubmed_authors><pubmed_authors>Moses J</pubmed_authors><pubmed_authors>Petersen NH</pubmed_authors><pubmed_authors>Schofer J</pubmed_authors><pubmed_authors>Bart van der Worp H</pubmed_authors><pubmed_authors>Lansky AJ</pubmed_authors><pubmed_authors>Kappetein AP</pubmed_authors><pubmed_authors>Virmani R</pubmed_authors><pubmed_authors>Zivadinov R</pubmed_authors><pubmed_authors>Pietras CG</pubmed_authors><pubmed_authors>Linke A</pubmed_authors><pubmed_authors>Greer D</pubmed_authors><pubmed_authors>Furie KL</pubmed_authors><pubmed_authors>Voros S</pubmed_authors><pubmed_authors>McFadden E</pubmed_authors><pubmed_authors>Baumbach A</pubmed_authors><pubmed_authors>Forrest JK</pubmed_authors><pubmed_authors>Lazar RM</pubmed_authors><pubmed_authors>Krucoff MW</pubmed_authors><pubmed_authors>Kapadia S</pubmed_authors><pubmed_authors>Cutlip DE</pubmed_authors><pubmed_authors>Prendergast B</pubmed_authors><pubmed_authors>Abrams KJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Proposed Standardized Neurological Endpoints for Cardiovascular Clinical Trials: An Academic Research Consortium Initiative.</name><description>Surgical and catheter-based cardiovascular procedures and adjunctive pharmacology have an inherent risk of neurological complications. The current diversity of neurological endpoint definitions and ascertainment methods in clinical trials has led to uncertainties in the neurological risk attributable to cardiovascular procedures and inconsistent evaluation of therapies intended to prevent or mitigate neurological injury. Benefit-risk assessment of such procedures should be on the basis of an evaluation of well-defined neurological outcomes that are ascertained with consistent methods and capture the full spectrum of neurovascular injury and its clinical effect. The Neurologic Academic Research Consortium is an international collaboration intended to establish consensus on the definition, c</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 May</publication><modification>2026-05-05T22:23:25.885Z</modification><creation>2019-06-06T23:04:32Z</creation></dates><accession>S-EPMC6251670</accession><cross_references><pubmed>28171522</pubmed><doi>10.1093/eurheartj/ehx037</doi></cross_references></HashMap>